Loading…
Concord Medical Services Holdings Limited is projected to rise to $4.80 by 2027, a +7% move from its current price of $4.50. CCM is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $4.33 | $4.51 | $4.69 | +0.12% |
| Aug 6 | $4.26 | $4.51 | $4.77 | +0.24% |
| Aug 7 | $4.21 | $4.52 | $4.84 | +0.36% |
| Aug 8 | $4.17 | $4.52 | $4.90 | +0.48% |
| Aug 9 | $4.14 | $4.53 | $4.95 | +0.60% |
| Aug 10 | $4.11 | $4.53 | $5.00 | +0.72% |
| Aug 11 | $4.08 | $4.54 | $5.05 | +0.84% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $4.08 | $4.54 | $5.05 | +0.84% |
| Week 2 | $3.94 | $4.58 | $5.32 | +1.68% |
| Week 3 | $3.84 | $4.61 | $5.54 | +2.53% |
| Week 4 | $3.76 | $4.65 | $5.75 | +3.39% |
| Week 5 | $3.70 | $4.69 | $5.95 | +4.26% |
| Week 6 | $3.65 | $4.73 | $6.13 | +5.13% |
| Week 7 | $3.60 | $4.77 | $6.32 | +6.01% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Concord Medical Services Holdings Limited operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. It operates in two segments, Network and Hospital.
Its services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services. Its other treatments and diagnostic services comprise positron emission tomography-computed tomography and magnetic resonance imaging scanners.
The company provides clinical support services, such as developing treatment protocols for doctors, organizing joint diagnosis between doctors in its network and clinical research, and helping to recruit and determine the compensation of doctors and other medical personnel. It offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, the company operates specialty cancer hospitals, which offers radiation, imaging, test laboratory, inpatient, and nursing services.
Concord Medical was founded in 1997 and is headquartered in Beijing, China.
Concord Medical Services Holdings Limited is a healthcare company operating a network of radiotherapy and diagnostic imaging centers in China. The stock trades at $4.51 and has a market cap of $19.58M, ranking 4698.
The longer-term price outlook is bullish, with forecasts showing growth in average prices across multiple years, including a 2026 average of $4.51, a 2030 average of $8.91, and a 2050 average of $44.75, along with higher potential highs in each period.
Forecasts indicate multi-year upside, with 2029 average $7.02 and 2031 average $9.75, supported by rising ROIs, culminating in a 2050 average of $44.75 and a max near $100.68. The implied sentiment shifts to BULLISH in the later years, suggesting meaningful upside versus the current level, though these figures are estimates and not guarantees.
A major floor 27.0% below — a decisive break under it would weaken the trend.
The nearest floor, 10.4% below — buyers have tended to step in here.
The nearest ceiling, 18.9% above — a clean break opens room to run.
A major ceiling 31.6% above — clearing it would confirm fresh momentum.
Key CCM support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CCM market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $4.52 | Sell | $4.48 | Buy |
| MA 10 | $4.35 | Buy | $4.45 | Buy |
| MA 20 | $4.49 | Buy | $4.48 | Buy |
| MA 50 | $4.66 | Sell | $4.54 | Sell |
| MA 100 | $4.40 | Buy | $4.50 | Buy |
| MA 200 | $4.38 | Buy | $4.60 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 48.26 | Neutral |
| Stoch RSI (14) | 67.57 | Neutral |
| CCI (20) | -18.10 | Neutral |
| Williams %R (14) | -35.48 | Info |
| MACD (12,26,9) | 0.03 | Buy |
| ROC (12) | -1.56 | Sell |
| Bollinger %B (20,2) | 0.44 | Neutral |
| Stochastic %K (14) | 64.52 | Neutral |
| TRIX (15) | -0.31 | Sell |
| Awesome (5,34) | -0.07 | Sell |
| Ultimate (7,14,28) | 50.32 | Neutral |
| Momentum (10) | 0.16 | Buy |
| Aroon Osc (25) | -28.00 | Sell |
| Hull MA (9) | 4.60 | Sell |
| ADX (14) | 8.95 | Neutral |
| ATR (14) | 0.18 | Info |
The 30-day technical picture is bullish.
RSI14 is 50, with the SMA50 at $4.73 and the SMA200 at $4.42. Support is seen at $4.03 and resistance at $5.47. The 30-day price range spans from $3.39 to $6.00, and annualized volatility is 80%.
Overall near-term dynamics point to constructive momentum within a defined trading band, framed by a clear support and resistance grid.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $3.43 | $4.50 | $6.27 | 0% | Neutral | |
| $3.67 | $4.80 | $6.74 | +7% | Neutral | |
| $3.91 | $5.34 | $7.89 | +19% | Neutral | |
| $4.84 | $6.87 | $10.55 | +53% | Bullish | |
| $6.00 | $8.79 | $13.96 | +95% | Bullish | |
| $6.46 | $9.76 | $15.97 | +117% | Bullish | |
| $6.11 | $9.49 | $15.92 | +111% | Bullish | |
| $6.51 | $10.39 | $17.84 | +131% | Bullish | |
| $6.66 | $10.91 | $19.12 | +142% | Bullish | |
| $6.66 | $11.18 | $19.97 | +148% | Bullish | |
| $8.88 | $16.73 | $32.38 | +272% | Bullish | |
| $19.74 | $43.86 | $95.16 | +875% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $3.43 | $4.50 | $5.46 | +0.00% |
| September 2026 | $3.97 | $4.76 | $5.91 | +5.83% |
| October 2026 | $4.14 | $5.02 | $6.32 | +5.34% |
| November 2026 | $4.03 | $4.92 | $6.27 | -2.02% |
| December 2026 | $3.95 | $4.86 | $6.27 | -1.11% |
Click any year to see its month-by-month CCM forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, CCM could reach as high as $6.27, with a base case around $4.50 and support toward $3.43 — roughly 0% from $4.50. Price action looks broadly range-bound.
Expect CCM to range from $3.67 to $6.74 through 2027. The $4.80 average target implies a +7% move from current prices. That is up +7% on the projected 2026 average. A consolidation phase looks the most probable path here.
The CCM price prediction for 2028 points to an average of $5.34 (low $3.91, high $7.89) — a potential gain of +19% on today's $4.50. Price action looks broadly range-bound.
In 2029, CCM is projected to trade between $4.84 and $10.55, averaging $6.87 — a potential gain of +53% from today's $4.50. That is up +29% on the projected 2028 average. Buyers look set to stay in control over this stretch.
Concord Medical Services Holdings Limited's 2030 outlook centres on $8.79, within a $6.00 to $13.96 range. That is up +28% on the projected 2029 average. That marks a +95% change versus current levels. Momentum favours further upside here.
By 2031, CCM could reach as high as $15.97, with a base case around $9.76 and support toward $6.46 — roughly +117% from $4.50. Buyers look set to stay in control over this stretch.
Expect CCM to range from $6.11 to $15.92 through 2032. The $9.49 average target implies a +111% move from current prices. That is -3% versus the projected 2031 average. Momentum favours further upside here.
The CCM price prediction for 2033 points to an average of $10.39 (low $6.51, high $17.84) — a potential gain of +131% on today's $4.50. Buyers look set to stay in control over this stretch.
In 2034, CCM is projected to trade between $6.66 and $19.12, averaging $10.91 — a potential gain of +142% from today's $4.50. That is up +5% on the projected 2033 average. Momentum favours further upside here.
Concord Medical Services Holdings Limited's 2035 outlook centres on $11.18, within a $6.66 to $19.97 range. That is up +2% on the projected 2034 average. That marks a +148% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, CCM could reach as high as $32.38, with a base case around $16.73 and support toward $8.88 — roughly +272% from $4.50. Momentum favours further upside here.
Expect CCM to range from $19.74 to $95.16 through 2050. The $43.86 average target implies a +875% move from current prices. That is up +162% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in CCM today (≈ 222.222222 CCM) could be worth
$9,746.2
+$8,746.2 (+875%) by 2050 · US Dollar
Based on the average projected CCM price of $43.86 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CCMwould be worth at today's price.
$1,000 invested in CCM on Jul 31, 2025 (≈ 200.803212 CCM) would be worth
$903.61
-$96.39 (-9.6%) today · 0.90× · US Dollar
Based on a CCM entry price of $4.98 vs. today's $4.5.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $4.3 | $1,046.51 | +4.7% |
| 1 month ago | $4.51 | $997.78 | -0.2% |
| 3 months ago | $3.95 | $1,139.24 | +13.9% |
| 6 months ago | $3.9 | $1,153.85 | +15.4% |
| 1 year ago | $4.98 | $903.61 | -9.6% |
| All time (5.0y) ago | $28.9 | $155.71 | -84.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CCM forecast.
Our base-case forecast reaches $9.00 around 2031.
Implied market cap at $9.00: $25.34M
The multi-year forecast shows substantial upside for CCM, with sentiment turning bullish in the later years. The average price is forecast to rise from $4.51 in 2026 to higher levels in 2030 and beyond, with progressively higher max values.
In 2030, the average price is $8.91, with a min of $5.94 and a max of $14.46. ROI is 97.5 and sentiment is BULLISH.
In 2040, the average price is $16.51 with ROI 266. In 2050, the average price is $44.75 with ROI 892.3 and a max of $100.68, with sentiment remaining BULLISH.
Forecasts are estimates, not guarantees, and should be considered in the context of risk and market volatility.
Tap a question to reveal the answer.
The forecast for 2030 shows an average price of $8.91, with a min of $5.94 and a max of $14.46; ROI is 97.5 and sentiment is BULLISH.
Forecasts show rising averages and high ROI in later years, including 2030 (avg $8.91, ROI 97.5) and 2050 (avg $44.75, ROI 892.3), with sentiment listed as BULLISH. These are estimates, not guarantees.
Yes. The 2050 forecast lists a max of $100.68.
Current price is $4.51 and market cap is $19.58M, with a rank of 4698.
The 30-day price range is $3.39 to $6.00.
Concord Medical Services Holdings Limited Community Discussion
0Share your Concord Medical Services Holdings Limited price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.